Editorial: Apatinib and Anlotinib in the Treatment of Radioactive Iodine Refractory and Highly Invasive Thyroid Carcinoma.

ABSTRACT: Thyroid cancer (TC) is the most prevalent endocrine malignancy, with a rising incidence in the past decade [...].

SUBMITTER: Jia W 

PROVIDER: S-EPMC9657471 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature